| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A potential role for imaging technology in anticancer efficacy evaluations
|
Hollingshead, M.G.
|
|
2004
|
40 |
6 |
p. 890-898
9 p.
|
artikel
|
| 2 |
Clonogenic assay with established human tumour xenografts
|
Fiebig, H.H
|
|
2004
|
40 |
6 |
p. 802-820
19 p.
|
artikel
|
| 3 |
Editorial board
|
|
|
2004
|
40 |
6 |
p. ii-
1 p.
|
artikel
|
| 4 |
Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development
|
Peterson, J.K.
|
|
2004
|
40 |
6 |
p. 837-844
8 p.
|
artikel
|
| 5 |
In vitro modelling of human tumour behaviour in drug discovery programmes
|
Baguley, B.C.
|
|
2004
|
40 |
6 |
p. 794-801
8 p.
|
artikel
|
| 6 |
In vivo models for endocrine-dependent breast carcinomas
|
Fichtner, I
|
|
2004
|
40 |
6 |
p. 845-851
7 p.
|
artikel
|
| 7 |
Modelling approaches for angiogenesis
|
Taraboletti, G.
|
|
2004
|
40 |
6 |
p. 881-889
9 p.
|
artikel
|
| 8 |
Multi-species toxicology approaches for oncology drugs
|
Tomaszewski, Joseph E.
|
|
2004
|
40 |
6 |
p. 907-913
7 p.
|
artikel
|
| 9 |
“Of mice and men”
|
Kelland, L.R.
|
|
2004
|
40 |
6 |
p. 827-836
10 p.
|
artikel
|
| 10 |
Orthotopic models of cancer for preclinical drug evaluation
|
Bibby, M.C.
|
|
2004
|
40 |
6 |
p. 852-857
6 p.
|
artikel
|
| 11 |
Preclinical models in cancer drug discovery and development
|
Sausville, E.A
|
|
2004
|
40 |
6 |
p. 783-784
2 p.
|
artikel
|
| 12 |
Spontaneous and genetically engineered animal models
|
Hansen, K
|
|
2004
|
40 |
6 |
p. 858-880
23 p.
|
artikel
|
| 13 |
The Cancer Research UK experience of pre-clinical toxicology studies to support early clinical trials with novel cancer therapies
|
Newell, D.R.
|
|
2004
|
40 |
6 |
p. 899-906
8 p.
|
artikel
|
| 14 |
The hollow fibre model in cancer drug screening
|
Decker, S.
|
|
2004
|
40 |
6 |
p. 821-826
6 p.
|
artikel
|
| 15 |
Update on NCI in vitro drug screen utilities
|
Holbeck, S.L
|
|
2004
|
40 |
6 |
p. 785-793
9 p.
|
artikel
|
Tijdschrift beschrijving